FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Agustin Avilés

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Activities & Behaviors

Actuarial Analysis

Co-author Network

Publications

TOP 3
Agustin Avilés; Natividad Neri; María-Jesús Nambo
Hematological malignancies and pregnancy: treat or no treat during first trimester.
Agustin Avilés; Raúl Fernández; Judith Huerta-Guzmán; Natividad Neri; M Jesús Nambo
Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma.
Natividad Neri; M Jesús Nambo; Agustin Avilés
Diffuse large B-cell lymphoma primary of lung.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Agustin Avilés (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Agustin Avilés; Natividad Neri; María-Jesús Nambo
Hematological malignancies and pregnancy: treat or no treat during first trimester.
International journal of cancer. Journal international du cancer 2012;131(11):2678-83.
2012: Agustin Avilés; Raúl Fernández; Judith Huerta-Guzmán; Natividad Neri; M Jesús Nambo
Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma.
International journal of radiation oncology, biology, physics 2012;83(4):1227-31.
2011: Natividad Neri; M Jesús Nambo; Agustin Avilés
Diffuse large B-cell lymphoma primary of lung.
Hematology (Amsterdam, Netherlands) 2011;16(2):110-2.
2011: Agustin Avilés; Natividad Neri
Multiple myeloma and pregnancy.
American journal of hematology 2011;86(1):81-2.
2010: Agustin Avilés; Natividad Neri; Judith Huerta-Guzmán; María de Jesús Nambo
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.
Clinical lymphoma, myeloma & leukemia 2010;10(2):125-8.
2009: Agustin Avilés; M Jesús Nambo; Sergio Cleto; Natividad Neri; Judith Huerta-Guzmán
Rituximab and dose-dense chemotherapy in primary testicular lymphoma.
Clinical lymphoma & myeloma 2009;9(5):386-9.
2009: Agustin Avilés; Claudia Castañeda; Sergio Cleto; Natividad Neri; Judith Huerta-Guzmán; Martha Gonzalez; M Jesús Nambo
Rituximab and chemotherapy in primary gastric lymphoma.
Cancer biotherapy & radiopharmaceuticals 2009;24(1):25-8.
2008: Agustin Avilés; Claudia Castañeda; Natividad Neri; Sergio Cleto; Alejandra Talavera; Martha González; Judith Huerta-Guzmán; M Jesús Nambo
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.
Medical oncology (Northwood, London, England) 2008;25(3):360-4.
2007: Agustin Avilés; M Jesús Nambo; Natividad Neri; Claudia Castañeda; Sergio Cleto; Martha Gonzalez; Judith Huerta-Guzmán
Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome.
Cancer biotherapy & radiopharmaceuticals 2007;22(6):836-40.
2007: Agustin Avilés; Claudia Castañeda; Natividad Neri; Sergio Cleto; M Jesús Nambo
Rituximab and dose dense chemotherapy in primary breast lymphoma.
Haematologica 2007;92(8):1147-8.
2007: Agustin Avilés; Sergio Cleto; Claudia Castañeda; M Jesús Nambo
CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Hematology (Amsterdam, Netherlands) 2007;12(3):241-4.
2007: Agustin Avilés; M Jesús Nambo; Claudia Castañeda; Sergio Cleto; Natividad Neri; Edgar Murillo; Judith Huerta-Guzmán; Margarita Contreras
Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trial.
Cancer biotherapy & radiopharmaceuticals 2007;22(2):194-9.
2007: Agustin Avilés; M Jesús Nambo; Natividad Neri; Claudia Castañeda; Sergio Cleto; Judith Huerta-Guzmán
Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma.
Medical oncology (Northwood, London, England) 2007;24(2):227-30.
2007: Agustin Avilés; M Jesús Nambo; Natividad Neri; Sergio Cleto; Claudia Castañeda; Judith Huerta-Guzmàn; Edgar Murillo; Margarita Contreras; Alejandra Talavera; Martha González
Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma.
Medical oncology (Northwood, London, England) 2007;24(1):85-9.
2006: Mónica Madrigal-Velázquez; Agustin Avilés; Natividad Neri; Judith Huerta; Guadalupe Martínez-Jaramillo; Hector Mayani
Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma.
Leukemia & lymphoma 2006;47(4):665-73.
2006: Agustin Avilés; Natividad Neri; M Jesús Nambo
Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):286-8.
2006: Agustin Avilés; Natividad Neri; Angel Calva; Judith Huerta-Guzmán; Sergio Cleto; M Jesús Nambo
Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit.
Oncology 2006;70(3):173-6.
2006: Agustin Avilés; Natividad Neri; M Jesús Nambo; Judith Huerta-Guzman; Sergio Cleto
Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
Medical oncology (Northwood, London, England) 2006;23(2):295-300.
2005: Agustin Avilés; Natividad Neri; M Jesús Nambo; Sergio Cleto; Claudia Castañeda; Martha González; Alejandra Talavera; Judith Huerta-Guzmán
Novel therapy in multiple myeloma.
Investigational new drugs 2005;23(5):411-5.
2005: Agustin Avilés; Natividad Neri; Jesús M Nambo; Judith Huerta-Guzman; Alejandra Talavera; Sergio Cleto
Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.
Leukemia & lymphoma 2005;46(7):1023-8.
2005: Agustin Avilés; M Jesús Nambo; Natividad Neri; Edgar Murillo; Claudia Castañeda; Sergio Cleto; Alejandra Talavera; Martha González
Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patients with multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):219-21.
2005: Agustin Avilés; Natividad Neri; Serafin Delgado; Felipe Pérez; M Jesús Nambo; Sergio Cleto; Alejandra Talavera; Judith Huerta-Guzmán
Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy.
Medical oncology (Northwood, London, England) 2005;22(4):383-7.
2005: Agustin Avilés; Serafin Delgado; M Jesús Nambo; Natividad Neri; Edgar Murillo; Sergio Cleto
Primary breast lymphoma: results of a controlled clinical trial.
Oncology 2005;69(3):256-60.
2005: Agustin Avilés; M Jesús Nambo; Natividad Neri; Alejandra Talavera; Sergio Cleto
Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial.
Medical oncology (Northwood, London, England) 2005;22(1):57-62.
2004: Agustin Avilés; Natividad Neri; Judith Huerta-Guzmán; Felipe Pérez; León Sotelo
Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
Leukemia & lymphoma 2004;45(11):2247-51.
2004: Agustin Avilés; Raúl Fernándezb; Felipe Pérez; M Jesús Nambo; Natividad Neri; Alejandra Talavera; Claudia Castañeda; Martha González; Sergio Cleto
Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome.
Leukemia & lymphoma 2004;45(7):1385-9.
2004: Agustin Avilés; M Jesús Nambo; Natividad Neri; Judith Huerta-Guzmán; Ivonne Cuadra; Isabel Alvarado; Claudia Castañeda; Raúl Fernández; Martha González
The role of surgery in primary gastric lymphoma: results of a controlled clinical trial.
Annals of surgery 2004;240(1):44-50.
2004: Guadalupe Martínez-Jaramillo; Agustin Avilés; Natividad Neri; Judith Huerta; Mónica Madrigal-Velazquez; Patricia Flores-Guzmán; Hector Mayani
In vitro proliferation and expansion of hematopoietic progenitors from patients with diffuse large B-cell lymphoma before and after chemotherapy.
Leukemia & lymphoma 2004;45(6):1247-54.
2004: Agustin Avilés; Natividad Neri; M Jesús Nambo; Claudia Castañeda; Alejandra Talavera; Judith Huerta-Guzmán; Edgar Murillo
Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma.
Stem cells and development 2004;13(2):205-9.
2004: Agustin Avilés; Natividad Neri; Judith Huerta-Guzmán; Felipe Pérez; Raúl Fernández
Testicular lymphoma: organ-specific treatment did not improve outcome.
Oncology 2004;67(3-4):211-4.
2004: Agustin Avilés; M Jesús Nambo; Natividad Neri; Alejandra Talavera; Claudia Castañeda; Edgar Murillo; Sergio Cleto; Judith Huerta-Guzmán
Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
Medical oncology (Northwood, London, England) 2004;21(3):269-72.
2004: Agustin Avilés; Natividad Neri; Judith Huerta-Guzmán; Raúl Fernández
Gemcitabine and cisplatin in refractory malignant lymphoma.
Oncology 2004;66(3):197-200.
2003: Agustin Avilés; Sergio Cleto; Natividad Neri; Judith Huerta-Guzmán; Alejandra Talavera; Claudia Castañeda; Martha González
Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy.
Leukemia & lymphoma 2003;44(8):1361-5.
2003: Agustin Avilés; Raúl Fernández; Angel Calva; Natividad Neri; Judith Huerta-Guzmán; M Jesús Nambo
Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.
Hematology (Amsterdam, Netherlands) 2003;8(1):7-10.
2003: Agustin Avilés; Leticia Valdez; José Halabe; Natividad Neri; Haiko Nellen; Judith Huerta-Guzmán; M Jesús Nambo
No association between lymphoma and hepatitis C virus.
Medical oncology (Northwood, London, England) 2003;20(2):165-8.
2003: Agustin Avilés; Natividad Neri; Ivonne Cuadra; Isabel Alvarado; Raúl Fernández; Angel Calva; Judith Huerta-Guzmán
Lack of prognostic factors in follicular lymphoma.
Leukemia & lymphoma 2003;44(1):143-7.
2003: Agustin Avilés; Natividad Neri; Raúl Fernández; Angel Calva; Judith Huerta-Guzmán; M Jesús Nambo
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Medical oncology (Northwood, London, England) 2003;20(1):13-7.
2002: Agustin Avilés; Edna L García; Raúl Fernández; J L Gonzalez; Natividad Neri; JC Díaz-Maqueo
Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Annals of hematology 2002;81(7):368-73.
2002: Agustin Avilés; Natividad Neri; Judith Huerta-Guzmán
Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients.
Journal of surgical oncology 2002;80(2):111-5.
2002: Agustin Avilés; Serafin Delgado; Raúl Fernández; Alejandra Talavera; Natividad Neri; Judith Huerta-Guzmán
Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial.
European journal of haematology 2002;68(3):144-9.
2002: Agustin Avilés; Raúl Fernández; José Luis González; Edna L García; Natividad Neri; Alejandra Talavera; José C Diaz-Maqueo
Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long-term analysis of treatments with radiotherapy, chemotherapy or combined therapy.
Leukemia & lymphoma 2002;43(2):355-9.
2002: Agustin Avilés; Natividad Neri; Claudia Castañeda; Alejandra Talavera; Judith Huerta-Guzmán; Martha González
Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma.
Medical oncology (Northwood, London, England) 2002;19(1):55-8.
2001: Agustin Avilés; Natividad Neri
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Clinical lymphoma 2001;2(3):173-7.
2001: Natividad Neri; Agustin Avilés; Sergio Cleto; N Díaz; Alejandra Talavera; Edna L García; JC Díaz-Maqueo
Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma.
Journal of hematotherapy & stem cell research 2001;10(5):669-74.
2001: Agustin Avilés; JC Díaz-Maqueo; Edna L García; Alejandra Talavera; Judith Huerta-Guzmán; Natividad Neri
Late lethal events in patients with diffuse large B cell lymphoma: a review of 714 patients treated in a single centre.
Leukemia & lymphoma 2001;42(4):631-7.
2001: Agustin Avilés; Alejandra Talavera; JC Díaz-Maqueo; Edna L García; Sergio Cleto; Natividad Neri
Evaluation on a six-dose treatment of anti CD 20 monoclonal antibody in patients with refractory follicular lymphoma.
Cancer biotherapy & radiopharmaceuticals 2001;16(2):159-62.
2001: Agustin Avilés; M I León; JC Díaz-Maqueo; Edna L García; Sergio Cleto; Natividad Neri
Rituximab in the treatment of refractory follicular lymphoma -- six doses are better than four.
Journal of hematotherapy & stem cell research 2001;10(2):313-6.
2001: Agustin Avilés; Sergio Cleto; Judith Huerta-Guzmán; Natividad Neri
Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens.
European journal of haematology 2001;66(2):94-9.
2001: Agustin Avilés; Natividad Neri; Edna L García; Alejandra Talavera; JC Díaz-Maqueo
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Medical oncology (Northwood, London, England) 2001;18(4):261-7.
2000: A Huerta-Zepeda; Alejandra Talavera; Agustin Avilés; Natividad Neri; Hector Mayani
In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy.
Leukemia & lymphoma 2000;39(5-6):613-24.
2000: Agustin Avilés; Natividad Neri; Ivonne Cuadra; Isabel Alvarado; Sergio Cleto
Second lethal events associated with treatment for Hodgkin's disease: a review of 2980 patients treated in a single Mexican institute.
Leukemia & lymphoma 2000;39(3-4):311-9.
2000: Agustin Avilés; N R Díaz; Natividad Neri; Sergio Cleto; Alejandra Talavera
Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients.
Clinical and laboratory haematology 2000;22(4):215-20.
1999: Agustin Avilés; Edna L García; Ivonne Cuadra; JC Díaz-Maqueo
High dose chemotherapy with G-CSF in refractory Hodgkin's disease.
Leukemia & lymphoma 1999;36(1-2):139-45.
1999: Agustin Avilés; José Halabe
Improved prognosis in patients with acquired immunodeficiency syndrome-related lymphoma.
Cancer biotherapy & radiopharmaceuticals 1999;14(5):349-52.
1999: Agustin Avilés; Alejandra Talavera; N R Díaz; Natividad Neri
Interferon as maintenance therapy in refractory malignant lymphoma.
Journal of hematotherapy 1999;8(3):263-7.
1999: Agustin Avilés; A Rosas; Judith Huerta-Guzmán; Alejandra Talavera; Sergio Cleto
Dexamethasone, all trans retinoic acid and interferon alpha 2a in patients with refractory multiple myeloma.
Cancer biotherapy & radiopharmaceuticals 1999;14(1):23-6.
1999: Agustin Avilés; M Jesús Nambo; José Halabe
Treatment of acquired immunodeficiency syndrome-related lymphoma with a standard chemotherapy regimen.
Annals of hematology 1999;78(1):9-12.
1998: Agustin Avilés; JC Díaz-Maqueo; Alejandra Talavera; M Jesús Nambo; Edna L García
Maintenance therapy with interferon alfa 2b in Hodgkin's disease.
Leukemia & lymphoma 1998;30(5-6):651-6.
1997: Agustin Avilés; M Jesús Nambo; Alejandra Talavera; E L Garcia; Judith Huerta-Guzman; JC Díaz-Maqueo
Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Anti-cancer drugs 1997;8(10):937-42.
1997: Agustin Avilés
The role of interferon as maintenance therapy in malignant lymphoma.
Medical oncology (Northwood, London, England) 1997;14(3-4):153-7.
1997: Agustin Avilés; JC Díaz-Maqueo; Alejandra Talavera; Edna L García; R Guzmán; M Jesús Nambo
Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1323-5.
1997: Agustin Avilés; Angel Calva; JC Díaz-Maqueo; Alejandra Talavera; Judith Huerta-Guzmán; E Vásquez
Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma.
Leukemia & lymphoma 1997;25(3-4):319-25.
1996: Agustin Avilés; S Delgado; Judith Huerta-Guzmán
Marginal zone B cell lymphoma of the parotid glands: results of a randomised trial comparing radiotherapy to combined therapy.
European journal of cancer. Part B, Oral oncology 1996;32B(6):420-2.
1996: Agustin Avilés; Judith Huerta-Guzmán; S Delgado; A Fernández; JC Díaz-Maqueo
Improved outcome in solitary bone plasmacytomata with combined therapy.
Hematological oncology 1996;14(3):111-7.
1996: Agustin Avilés; R Guzmán; S Delgado; M Jesús Nambo; Edna L García; JC Díaz-Maqueo
Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
American journal of hematology 1996;52(4):275-80.
1996: Agustin Avilés; R Guzmán; Edna L García; Alejandra Talavera; JC Díaz-Maqueo
Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia.
Anti-cancer drugs 1996;7(4):392-7.
1996: Agustin Avilés; R Guzmán; Edna L García; JC Díaz-Maqueo
Biological modifiers (etretinate (changed from etetrinate) and alfa 2a) in the treatment of refractory cutaneous T-cell lymphoma.
Cancer biotherapy & radiopharmaceuticals 1996;11(1):21-4.
1996: Agustin Avilés; S Delgado; H Ruiz; A de la Torre; R Guzman; Alejandra Talavera
Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy.
European journal of cancer. Part B, Oral oncology 1996;32B(1):19-23.
1995: Agustin Avilés; M Jesús Nambo; Alejandra Talavera; A Rosas; Edna L García; JC Díaz-Maqueo
GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma.
Leukemia & lymphoma 1995;17(3-4):327-30.
1995: Agustin Avilés; B Soto; R Guzmán; Edna L García; M Jesús Nambo; JC Díaz-Maqueo
Results of a randomized study of early stage Hodgkin's disease using ABVD, EBVD, or MBVD.
Medical and pediatric oncology 1995;24(3):171-5.
1995: Agustin Avilés; Alejandra Talavera; R Guzmán; I Cuadra
Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy.
Cancer biotherapy 1995;10(4):273-7.
1994: Agustin Avilés; S Delgado; M Jesús Nambo; S Alatriste; JC Díaz-Maqueo
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
International journal of radiation oncology, biology, physics 1994;30(4):799-803.
1994: Agustin Avilés; S Delgado; A Fernández; M Jesús Nambo; A Rosas
Combined therapy for angioimmunoproliferative lesions.
European journal of cancer. Part B, Oral oncology 1994;30B(5):302-4.
1994: Agustin Avilés; JC Díaz-Maqueo; Alejandra Talavera; M Jesús Nambo; Edna L García
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Leukemia & lymphoma 1994;15(1-2):153-7.
1994: Agustin Avilés; R Guzmán; Alejandra Talavera; Edna L García; JC Díaz-Maqueo
Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin, and dacarbazine (EVBD) versus mitoxantrone, vinblastine, bleomycin, and dacarbazine (MVBD).
Medical and pediatric oncology 1994;22(3):168-72.
1993: Agustin Avilés; N Arévila; JC Díaz-Maqueo; T Gómez; R García; M Jesús Nambo
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Leukemia & lymphoma 1993;11(3-4):275-9.
1993: Agustin Avilés; B R Narváez; JC Díaz-Maqueo; R Guzmán; Alejandra Talavera; Edna L García
Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
Leukemia & lymphoma 1993;9(4-5):377-80.
1992: Agustin Avilés; JC Díaz-Maqueo; Edna L García; Alejandra Talavera; R Guzmán
Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma.
Investigational new drugs 1992;10(4):351-5.
1992: Agustin Avilés; V Torras; H D Cortés; J Ramón Ayala; JC Díaz-Maqueo
[Lymphoblastic lymphoma in the adult].
Gaceta médica de México 1992;128(4):369-73.
1992: Agustin Avilés; R Guzmán; Edna L García; Alejandra Talavera; JC Díaz-Maqueo
[The role of radiotherapy in the early stages of Hodgkin's disease].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1992;44(3):363-8.
1992: Agustin Avilés; G Zepeda; JC Díaz-Maqueo; L Rodriguez; R Guzmán; Edna L García; Alejandra Talavera
Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
Leukemia & lymphoma 1992;7(1-2):135-8.
1992: Agustin Avilés; G Zepeda; R Guzmán; Alejandra Talavera; Edna L García; JC Díaz-Maqueo
[Prognostic importance of beta-2-microglobulin in multiple myeloma].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1992;44(2):215-20.
1992: Agustin Avilés; JC Díaz-Maqueo; J R Ayala; H D Cortés; Edna L García
Hodgkin's disease and acute leukemia. Is it a true association?
Archives of medical research 1992;23(1):65-8.
1991: Agustin Avilés; R Guzmán; J Huerta; JC Díaz-Maqueo
[Retrospective analysis of prognostic factors in patients with primary lymphoma of the intestine].
Revista de gastroenterología de México 1991;56(4):217-21.
1991: Agustin Avilés; G Zepeda; J Cruz
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants].
Boletín médico del Hospital Infantil de México 1991;48(9):622-6.
1991: Agustin Avilés; JC Díaz-Maqueo; Alejandra Talavera; R Guzmán; Edna L García
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
American journal of hematology 1991;36(4):243-8.
1991: Agustin Avilés; JC Díaz-Maqueo; L Rodriguez; Edna L García; R Guzmán; Alejandra Talavera
Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.
Hematological oncology 1991;9(2):115-21.
1991: Agustin Avilés; Edna L García; Alejandra Talavera; R Guzmán; J C Diáz-Maqueo
[Preinduction in the treatment of patients with malignant lymphoma].
Gaceta médica de México 1991;127(2):119-23.
1991: Agustin Avilés; JC Díaz-Maqueo; E Sánchez; H D Córtes; J R Ayala
Long-term results in patients with low-grade nodular non-Hodgkin's lymphoma. A randomized trial comparing chemotherapy plus radiotherapy with chemotherapy alone.
Acta oncologica (Stockholm, Sweden) 1991;30(3):329-33.
1991: Agustin Avilés; JC Díaz-Maqueo; Edna L García; V Torras; D López-Vancell
Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Archivos de investigación médica 1991;22(1):45-50.
1991: Agustin Avilés; JC Díaz-Maqueo; V Torras; J R Ayala; H D Cortés
Hodgkin's disease. A historical perspective.
Archivos de investigación médica 1991;22(1):27-33.
1991: Agustin Avilés; J Huerta; G Zepeda; R Guzmán; JC Díaz-Maqueo
The role of maintenance therapy in the treatment of large-cell non-Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 1991;30(8):959-62.
1990: Agustin Avilés; J Huerta; G Zepeda; JC Díaz-Maqueo
Serum beta 2 microglobulin in solitary plasmocytomata.
Blood 1990;76(8):1663.
1990: Agustin Avilés; Alejandra Talavera; Edna L García; R Guzmán; JC Díaz-Maqueo
[Alkaline phosphatase as a prognostic factor in Hodgkin's disease].
Revista de gastroenterología de México 1990;55(4):211-4.
1990: Agustin Avilés; J Huerta; R Guzmán; G Zepeda; JC Díaz-Maqueo
[CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1990;42(4):271-6.
1990: Agustin Avilés; JC Díaz-Maqueo; V Torras; R Guzman
[Hodgkin's disease treated with chemotherapy at reduced dosage].
Sangre 1990;35(5):341-4.
1990: Agustin Avilés; JC Díaz-Maqueo; V Torras; L Rodríguez; D López Vancell
[Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
Sangre 1990;35(4):245-9.
1990: Agustin Avilés; JC Díaz-Maqueo; V Torras; Edna L García; R Guzmán
Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases.
Gynecologic oncology 1990;37(3):335-7.
1990: Agustin Avilés; JC Díaz-Maqueo; Alejandra Talavera; Edna L García
[Granulocyte-macrophage colony-stimulating factor in the treatment of secondary bone marrow suppression in patients with lymphoma. Preliminary report].
Archivos de investigación médica 1990;21(2):133-7.
1990: Agustin Avilés; JC Díaz-Maqueo; V Torras
[Treatment of refractory malignant lymphomas with cisplatin, vinblastine, and bleomycin].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1990;42(2):99-102.
1990: Agustin Avilés; JC Díaz-Maqueo; L Rodríguez; Edna L García; V Torras; R Guzmán
Group risk classification of non-Hodgkin's lymphoma.
Archivos de investigación médica 1990;21(1):11-6.
1989: Agustin Avilés; JC Díaz-Maqueo; N Arévila-Ceballos; R García Fernández; D López-Vancell; V Torras
[Evaluation of ventricular function in patients treated with mitoxantrone and 4'-epidoxorubicin].
Archivos del Instituto de Cardiología de México 1989;59(6):615-8.
1989: JC Díaz-Maqueo; Agustin Avilés; Edna L García; L Rodríguez; D López-Vancell; V Torras; R Guzmán
[Long-term results in the treatment of lymphomas using polychemotherapy (CHOP)].
Sangre 1989;34(5):332-6.
1989: JC Díaz-Maqueo; Agustin Avilés; L Rodríguez; D López-Vancell; Edna L García; R Guzmán
[Prognosis determination in patients with malignant lymphoma].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1989;41(3):235-9.